One Stop Shop for All Your Market Research Reports

Global Antivenom Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection. According to our (Global Info Research) latest study, the global Antivenom market size was valued at USD 987 million in 2022 and is forecast to a readjusted size of USD 1300.5 million by 2029 with a CAGR of 4.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019. This report is a detailed and comprehensive analysis for global Antivenom market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Antivenom market size and forecasts, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029 Global Antivenom market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029 Global Antivenom market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Vials), and average selling prices (USD/Vial), 2018-2029 Global Antivenom market shares of main players, shipments in revenue ($ Million), sales quantity (K Vials), and ASP (USD/Vial), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Antivenom To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Antivenom market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer and Haffkine Bio-Pharmaceutical, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Antivenom market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Polyvalent antivenom Monovalent antivenom Market segment by Application Non-profit Institutions Hospitals and Clinic Major players covered CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Rare Disease Therapeutics Flynn Pharma Vins Bioproducts Bharat Serums and Vaccines Serum Biotech MicroPharm Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Antivenom product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Antivenom, with price, sales, revenue and global market share of Antivenom from 2018 to 2023. Chapter 3, the Antivenom competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Antivenom breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antivenom market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Antivenom. Chapter 14 and 15, to describe Antivenom sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Antivenom 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Antivenom Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Polyvalent antivenom 1.3.3 Monovalent antivenom 1.4 Market Analysis by Application 1.4.1 Overview: Global Antivenom Consump
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 219173
Category
  • Pharmaceuticals and Healthcare
Published on 22-Mar
Number of Pages 101
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(42)